866-997-4948(US-Canada Toll Free)

Europe Antidote Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 120 Pages

Notes:
Sales, means the sales volume of Antidote
Revenue, means the sales value of Antidote

This report studies sales (consumption) of Antidote in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Boehringer Ingelheim Pharmaceuticals
AstraZeneca
Novartis International
Eli Lilly and Company

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Antidote in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Chemical Antidotes
Physical Antidotes
Pharmacological Antidotes

Split by application, this report focuses on sales, market share and growth rate of Antidote in each application, can be divided into
Application 1
Application 2

Table of Contents

Europe Antidote Market Report 2017
1 Antidote Overview
1.1 Product Overview and Scope of Antidote
1.2 Classification of Antidote
1.2.1 Chemical Antidotes
1.2.2 Physical Antidotes
1.2.3 Pharmacological Antidotes
1.3 Application of Antidote
1.3.1 Application 1
1.3.2 Application 2
1.4 Antidote Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Antidote (2012-2022)
1.5.1 Europe Antidote Sales and Growth Rate (2012-2022)
1.5.2 Europe Antidote Revenue and Growth Rate (2012-2022)

2 Europe Antidote by Manufacturers, Type and Application
2.1 Europe Antidote Market Competition by Manufacturers
2.1.1 Europe Antidote Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Antidote Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Antidote (Volume and Value) by Type
2.2.1 Europe Antidote Sales and Market Share by Type (2012-2017)
2.2.2 Europe Antidote Revenue and Market Share by Type (2012-2017)
2.3 Europe Antidote (Volume and Value) by Countries
2.3.1 Europe Antidote Sales and Market Share by Countries (2012-2017)
2.3.2 Europe Antidote Revenue and Market Share by Countries (2012-2017)
2.4 Europe Antidote (Volume) by Application

3 Germany Antidote (Volume, Value and Sales Price)
3.1 Germany Antidote Sales and Value (2012-2017)
3.1.1 Germany Antidote Sales and Growth Rate (2012-2017)
3.1.2 Germany Antidote Revenue and Growth Rate (2012-2017)
3.1.3 Germany Antidote Sales Price Trend (2012-2017)
3.2 Germany Antidote Sales and Market Share by Manufacturers
3.3 Germany Antidote Sales and Market Share by Type
3.4 Germany Antidote Sales and Market Share by Application

4 France Antidote (Volume, Value and Sales Price)
4.1 France Antidote Sales and Value (2012-2017)
4.1.1 France Antidote Sales and Growth Rate (2012-2017)
4.1.2 France Antidote Revenue and Growth Rate (2012-2017)
4.1.4 France Antidote Sales Price Trend (2012-2017)
4.2 France Antidote Sales and Market Share by Manufacturers
4.3 France Antidote Sales and Market Share by Type
4.4 France Antidote Sales and Market Share by Application

5 UK Antidote (Volume, Value and Sales Price)
5.1 UK Antidote Sales and Value (2012-2017)
5.1.1 UK Antidote Sales and Growth Rate (2012-2017)
5.1.2 UK Antidote Revenue and Growth Rate (2012-2017)
5.1.5 UK Antidote Sales Price Trend (2012-2017)
5.2 UK Antidote Sales and Market Share by Manufacturers
5.3 UK Antidote Sales and Market Share by Type
5.4 UK Antidote Sales and Market Share by Application

6 Russia Antidote (Volume, Value and Sales Price)
6.1 Russia Antidote Sales and Value (2012-2017)
6.1.1 Russia Antidote Sales and Growth Rate (2012-2017)
6.1.2 Russia Antidote Revenue and Growth Rate (2012-2017)
6.1.6 Russia Antidote Sales Price Trend (2012-2017)
6.2 Russia Antidote Sales and Market Share by Manufacturers
6.3 Russia Antidote Sales and Market Share by Type
6.4 Russia Antidote Sales and Market Share by Application

7 Italy Antidote (Volume, Value and Sales Price)
7.1 Italy Antidote Sales and Value (2012-2017)
7.1.1 Italy Antidote Sales and Growth Rate (2012-2017)
7.1.2 Italy Antidote Revenue and Growth Rate (2012-2017)
7.1.7 Italy Antidote Sales Price Trend (2012-2017)
7.2 Italy Antidote Sales and Market Share by Manufacturers
7.3 Italy Antidote Sales and Market Share by Type
7.4 Italy Antidote Sales and Market Share by Application

8 Spain Antidote (Volume, Value and Sales Price)
8.1 Spain Antidote Sales and Value (2012-2017)
8.1.1 Spain Antidote Sales and Growth Rate (2012-2017)
8.1.2 Spain Antidote Revenue and Growth Rate (2012-2017)
8.1.8 Spain Antidote Sales Price Trend (2012-2017)
8.2 Spain Antidote Sales and Market Share by Manufacturers
8.3 Spain Antidote Sales and Market Share by Type
8.4 Spain Antidote Sales and Market Share by Application

9 Benelux Antidote (Volume, Value and Sales Price)
9.1 Benelux Antidote Sales and Value (2012-2017)
9.1.1 Benelux Antidote Sales and Growth Rate (2012-2017)
9.1.2 Benelux Antidote Revenue and Growth Rate (2012-2017)
9.1.9 Benelux Antidote Sales Price Trend (2012-2017)
9.2 Benelux Antidote Sales and Market Share by Manufacturers
9.3 Benelux Antidote Sales and Market Share by Type
9.4 Benelux Antidote Sales and Market Share by Application

10 Europe Antidote Manufacturers Analysis
10.1 Boehringer Ingelheim Pharmaceuticals
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Antidote Product Type, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Boehringer Ingelheim Pharmaceuticals Antidote Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 AstraZeneca
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Antidote Product Type, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 AstraZeneca Antidote Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Novartis International
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Antidote Product Type, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Novartis International Antidote Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Eli Lilly and Company
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Antidote Product Type, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Eli Lilly and Company Antidote Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview

11 Antidote Manufacturing Cost Analysis
11.1 Antidote Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Antidote

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Antidote Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Antidote Major Manufacturers in 2015
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Europe Antidote Market Forecast (2017-2022)
14.1 Germany Antidote Sales Forecast (2017-2022)
14.2 France Antidote Sales Forecast (2017-2022)
14.3 UK Antidote Sales Forecast (2017-2022)
14.4 Russia Antidote Sales Forecast (2017-2022)
14.5 Italy Antidote Sales Forecast (2017-2022)
14.6 Spain Antidote Sales Forecast (2017-2022)
14.7 Benelux Antidote Sales Forecast (2017-2022)
14.8 Europe Antidote Sales Forecast by Type (2017-2022)
14.9 Europe Antidote Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source


List of Table

List of Tables and Figures

Figure Picture of Antidote
Table Classification of Antidote
Figure Europe Sales Market Share of Antidote by Type in 2015
Figure Chemical Antidotes Picture
Figure Physical Antidotes Picture
Figure Pharmacological Antidotes Picture
Table Application of Antidote
Figure Europe Sales Market Share of Antidote by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Antidote Revenue and Growth Rate (2012-2022)
Figure France Antidote Revenue and Growth Rate (2012-2022)
Figure UK Antidote Revenue and Growth Rate (2012-2022)
Figure Russia Antidote Revenue and Growth Rate (2012-2022)
Figure Italy Antidote Revenue and Growth Rate (2012-2022)
Figure Spain Antidote Revenue and Growth Rate (2012-2022)
Figure Benelux Antidote Revenue and Growth Rate (2012-2022)
Figure Europe Antidote Sales and Growth Rate (2012-2022)
Figure Europe Antidote Revenue and Growth Rate (2012-2022)
Table Europe Antidote Sales of Key Manufacturers (2015 and 2016)
Table Europe Antidote Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antidote Sales Share by Manufacturers
Figure 2016 Antidote Sales Share by Manufacturers
Table Europe Antidote Revenue by Manufacturers (2015 and 2016)
Table Europe Antidote Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Antidote Revenue Share by Manufacturers
Table 2016 Europe Antidote Revenue Share by Manufacturers
Table Europe Antidote Sales and Market Share by Type (2012-2017)
Table Europe Antidote Sales Share by Type (2012-2017)
Figure Sales Market Share of Antidote by Type (2012-2017)
Figure Europe Antidote Sales Growth Rate by Type (2012-2017)
Table Europe Antidote Revenue and Market Share by Type (2012-2017)
Table Europe Antidote Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antidote by Type (2012-2017)
Figure Europe Antidote Revenue Growth Rate by Type (2012-2017)
Table Europe Antidote Sales and Market Share by Countries (2012-2017)
Table Europe Antidote Sales Share by Countries (2012-2017)
Figure Sales Market Share of Antidote by Countries (2012-2017)
Table Europe Antidote Revenue and Market Share by Countries (2012-2017)
Table Europe Antidote Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Antidote by Countries (2012-2017)
Table Europe Antidote Sales and Market Share by Application (2012-2017)
Table Europe Antidote Sales Share by Application (2012-2017)
Figure Sales Market Share of Antidote by Application (2012-2017)
Figure Germany Antidote Sales and Growth Rate (2012-2017)
Figure Germany Antidote Revenue and Growth Rate (2012-2017)
Figure Germany Antidote Sales Price Trend (2012-2017)
Table Germany Antidote Sales by Manufacturers (2015 and 2016)
Table Germany Antidote Market Share by Manufacturers (2015 and 2016)
Table Germany Antidote Sales by Type (2015 and 2016)
Table Germany Antidote Market Share by Type (2015 and 2016)
Table Germany Antidote Sales by Application (2015 and 2016)
Table Germany Antidote Market Share by Application (2015 and 2016)
Figure France Antidote Sales and Growth Rate (2012-2017)
Figure France Antidote Revenue and Growth Rate (2012-2017)
Figure France Antidote Sales Price Trend (2012-2017)
Table France Antidote Sales by Manufacturers (2015 and 2016)
Table France Antidote Market Share by Manufacturers (2015 and 2016)
Table France Antidote Sales by Type (2015 and 2016)
Table France Antidote Market Share by Type (2015 and 2016)
Table France Antidote Sales by Application (2015 and 2016)
Table France Antidote Market Share by Application (2015 and 2016)
Figure UK Antidote Sales and Growth Rate (2012-2017)
Figure UK Antidote Revenue and Growth Rate (2012-2017)
Figure UK Antidote Sales Price Trend (2012-2017)
Table UK Antidote Sales by Manufacturers (2015 and 2016)
Table UK Antidote Market Share by Manufacturers (2015 and 2016)
Table UK Antidote Sales by Type (2015 and 2016)
Table UK Antidote Market Share by Type (2015 and 2016)
Table UK Antidote Sales by Application (2015 and 2016)
Table UK Antidote Market Share by Application (2015 and 2016)
Figure Russia Antidote Sales and Growth Rate (2012-2017)
Figure Russia Antidote Revenue and Growth Rate (2012-2017)
Figure Russia Antidote Sales Price Trend (2012-2017)
Table Russia Antidote Sales by Manufacturers (2015 and 2016)
Table Russia Antidote Market Share by Manufacturers (2015 and 2016)
Table Russia Antidote Sales by Type (2015 and 2016)
Table Russia Antidote Market Share by Type (2015 and 2016)
Table Russia Antidote Sales by Application (2015 and 2016)
Table Russia Antidote Market Share by Application (2015 and 2016)
Figure Italy Antidote Sales and Growth Rate (2012-2017)
Figure Italy Antidote Revenue and Growth Rate (2012-2017)
Figure Italy Antidote Sales Price Trend (2012-2017)
Table Italy Antidote Sales by Manufacturers (2015 and 2016)
Table Italy Antidote Market Share by Manufacturers (2015 and 2016)
Table Italy Antidote Sales by Type (2015 and 2016)
Table Italy Antidote Market Share by Type (2015 and 2016)
Table Italy Antidote Sales by Application (2015 and 2016)
Table Italy Antidote Market Share by Application (2015 and 2016)
Figure Spain Antidote Sales and Growth Rate (2012-2017)
Figure Spain Antidote Revenue and Growth Rate (2012-2017)
Figure Spain Antidote Sales Price Trend (2012-2017)
Table Spain Antidote Sales by Manufacturers (2015 and 2016)
Table Spain Antidote Market Share by Manufacturers (2015 and 2016)
Table Spain Antidote Sales by Type (2015 and 2016)
Table Spain Antidote Market Share by Type (2015 and 2016)
Table Spain Antidote Sales by Application (2015 and 2016)
Table Spain Antidote Market Share by Application (2015 and 2016)
Figure Benelux Antidote Sales and Growth Rate (2012-2017)
Figure Benelux Antidote Revenue and Growth Rate (2012-2017)
Figure Benelux Antidote Sales Price Trend (2012-2017)
Table Benelux Antidote Sales by Manufacturers (2015 and 2016)
Table Benelux Antidote Market Share by Manufacturers (2015 and 2016)
Table Benelux Antidote Sales by Type (2015 and 2016)
Table Benelux Antidote Market Share by Type (2015 and 2016)
Table Benelux Antidote Sales by Application (2015 and 2016)
Table Benelux Antidote Market Share by Application (2015 and 2016)
Table Antidote Basic Information List
Table Boehringer Ingelheim Pharmaceuticals Antidote Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Pharmaceuticals Antidote Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Antidote Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Antidote Sales Market Share (2012-2017)
Table Novartis International Basic Information List
Table Novartis International Antidote Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis International Antidote Sales Market Share (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Antidote Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly and Company Antidote Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antidote
Figure Manufacturing Process Analysis of Antidote
Figure Antidote Industrial Chain Analysis
Table Raw Materials Sources of Antidote Major Manufacturers in 2015
Table Major Buyers of Antidote
Table Distributors/Traders List
Figure Germany Antidote Sales and Growth Rate Forecast (2017-2022)
Figure Germany Antidote Revenue and Growth Rate Forecast (2017-2022)
Figure France Antidote Sales and Growth Rate Forecast (2017-2022)
Figure France Antidote Revenue and Growth Rate Forecast (2017-2022)
Figure UK Antidote Sales and Growth Rate Forecast (2017-2022)
Figure UK Antidote Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Antidote Sales and Growth Rate Forecast (2017-2022)
Figure Russia Antidote Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Antidote Sales and Growth Rate Forecast (2017-2022)
Figure Italy Antidote Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Antidote Sales and Growth Rate Forecast (2017-2022)
Figure Spain Antidote Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Antidote Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Antidote Revenue and Growth Rate Forecast (2017-2022)
Table Europe Antidote Sales Forecast by Type (2017-2022)
Table Europe Antidote Sales Forecast by Application (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *